NAD Kinase, human recombinant protein
NADK; Poly (P)/ATP NAD Kinase; EC 2.7.1.23.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O95544 |
---|---|
Concentration | 1 |
Calculated MW | ~50 kDa (monomer). Human full length NAD kinase (aa 1-446) is fused at the N-terminus to a His-tag. |
Gene ID | 65220 |
---|---|
Gene Symbol | NADK |
Other Names | NADK; Poly (P)/ATP NAD Kinase; EC 2.7.1.23. |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | N/A; |
Recombinant | Yes |
Results | ≥ 1U/mg protein. One unit is defined as the amount of enzyme that synthesizes 1 µmol of NADP per min. |
Target/Specificity | NAD Kinase |
Format | Liquid |
Storage | -20°C; 1 mg/ml of ammonium sulphate suspension. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis.
References
Lerner F.,et al.Biochem. Biophys. Res. Commun. 288:69-74(2001).
Xu X.,et al.Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Gregory S.G.,et al.Nature 441:315-321(2006).
Mural R.J.,et al.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.